Right Drug, Right Patient, Right Time
Find out moreTeam Science
Our V funded researchers and scientists. An all-star lineup for the future of cancer research, helping to accelerate victory over cancer and save lives
Right Drug, Right Patient, Right Time
How Multi-Time Grantee Christina Curtis, Ph.D., Continues to Develop Advancements in Breast…
Find out moreKaren Sfanos, Ph.D.: Dedicated Researcher with a Unique Perspective
How Dr. Sfanos’ Personal Cancer Battle Provided a Unique Perspective as a…
Find out more“The Victories in the Clinic are Worth It”
How Dr. Gruber is Building off V Foundation-Funded Groundwork
Find out moreBattling the Unique Cancer Challenges Faced by the LGBTQ Community
How Matthew Schabath, Ph.D., and Moffitt Cancer Center are Leading the Way…
Find out moreHow Dr. Felix Feng is Aiming for the Holy Grail in Prostate Cancer Research
Utilizing Cutting-Edge Artificial Intelligence Technologies to Advance Treatment Plans for Prostate Cancer…
Find out moreCancer researcher’s goal is to make global impact, save generations to come
V Foundation grantee Debattama Sen, Ph.D., was featured on Healio.com, discussing her…
Find out moreUnderstanding When – and Whether – to Treat Childhood Myelodysplastic Syndrome
Jason Schwartz, M.D., Ph.D., Researching Gene Mutations That Could Help Identify Better…
Find out moreZhu Surprised with Pediatric All-Star Grant
Shizhen (Jane) Zhu, M.D., Ph.D., was awarded a Pediatric All-Star Grant through…
Find out moreCancer Research Collaboration for Scientists at the V Summit
Working together to achieve Victory Over Cancer®. That synergy of the top…
Find out moreFinding hope for ovarian cancer with a new perspective on ‘undruggable’ targets
Each year, about 20,000 women in the U.S. are diagnosed with ovarian…
Find out moreResearcher And Patient: Dr. Deming Knows Cancer from Both Views
In the medical profession, a key aspect of building rapport with patients…
Find out moreRare disease reveals new insights into head and neck cancers
People with the genetic disease Fanconi anemia have a risk of developing…
Find out more
Mailing List
